Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors from the central nervous program, conolidine modulates alternate molecular targets. A Science Developments examine located that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR